Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
132
Frequently Asked Questions
What is Market Cap of Co-Diagnostics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Co-Diagnostics Inc market cap is $11.93M.
What is the 52-week high for Co-Diagnostics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Co-Diagnostics Inc 52 week high is $1.40 as of September 07, 2025.
What is the 52-week low for Co-Diagnostics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Co-Diagnostics Inc 52 week low is $0.2275 as of September 07, 2025.
What is Co-Diagnostics Inc stock price today?
Co-Diagnostics Inc stock price today is $0.3098.
What was Co-Diagnostics Inc stock price yesterday?
Co-Diagnostics Inc stock price yesterday was $0.3089.
What is the PE ratio of Co-Diagnostics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Co-Diagnostics Inc’s P/E ratio is -0.28.
What is the Price-to-Book ratio of Co-Diagnostics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Co-Diagnostics Inc P/B ratio is 0.2725.
What is the 50-day moving average of Co-Diagnostics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Co-Diagnostics Inc 50-day moving average is $0.281.
CODX Co-Diagnostics Inc